Citations

Citations to this article as recorded by  

• Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database
  Minyoung Lee, Kyeongseob Jeong, Yu Rang Park, Yumie Rhee
  Metabolism.2023; 138: 155311.     CrossRef
• The ameliorating effects of mesenchymal stem cells compared to α‐tocopherol on apoptosis and autophagy in streptozotocin‐induced diabetic rats: Implication of PI3K/Akt signaling pathway and entero‐insular axis
  Heba A. Mubarak, Manal M. Kamal, Yossra Mahmoud, Fatma S. Abd‐Elsamea, Eman Abdelbary, Marwa G. Gamea, Reham I. El‐Mahdy
  Journal of Cellular Biochemistry.2023; 124(11): 1705.     CrossRef
• Leptin Rs7799039 polymorphism is associated with type 2 diabetes mellitus Egyptian patients
  Amal Ahmed Mohamed, Dina M. Abo-Elmatty, Alaa S. Wahba, Omnia Ezzat Esmail, Hadeer Saied Mahmoud Salim, Wafaa Salah Mohammed Hegab, Mona Mostafa Farid Ghanem, Nadia Youssef Riad, Doaa Ghaith, Lamiaa I Daker, Shorouk Issa, Noha Hassan Radwan, Eman Sultan,
  Archives of Physiology and Biochemistry.2023; : 1.     CrossRef
• Association of Polygenic Variants with Type 2 Diabetes Risk and Their Interaction with Lifestyles in Asians
  Haeng Jeon Hur, Hye Jeong Yang, Min Jung Kim, Kyun-Hee Lee, Myung-Sunny Kim, Sunmin Park
  Nutrients.2022; 14(15): 3222.     CrossRef
• Chemical Compounds and Ambient Factors Affecting Pancreatic Alpha-Cells Mass and Function: What Evidence?
  Gaia Chiara Mannino, Elettra Mancuso, Stefano Sbrignadello, Micaela Morettini, Francesco Andreozzi, Andrea Tura
  International Journal of Environmental Research and Public Health.2022; 19(24): 16489.     CrossRef

Citations

Citations to this article as recorded by  

• Clinical value of serum MMP-3 in chronic kidney disease
  Yulin Fu, Cheng Song, Yuan Qin, Tianyu Zheng, Xiumei Zhou, Xueqin Zhao, Jian Zou, Biao Huang
  Clinica Chimica Acta.2024; 553: 117725.     CrossRef
• β2-Adrenergic receptor agonists as a treatment for diabetic kidney disease
  Ehtesham Arif, Danira Medunjanin, Ashish Solanki, Xiaofeng Zuo, Yanhui Su, Yujing Dang, Brennan Winkler, Kasey Lerner, Ahmed I. Kamal, Oleg Palygin, Marc-Andre Cornier, Bethany J. Wolf, Kelly J. Hunt, Joshua H. Lipschutz
  American Journal of Physiology-Renal Physiology.2024; 326(1): F20.     CrossRef
• β2-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?
  Zhiwen Liu, Zheng Dong
  American Journal of Physiology-Renal Physiology.2024; 326(1): F1.     CrossRef
• Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease
  Lu-Lu Han, Sheng-Hai Wang, Ming-Yan Yao, Hong Zhou
  World Journal of Diabetes.2024; 15(1): 92.     CrossRef
• Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway
  Honghong Liu, Jiao Wang, Guanru Yue, Jixiong Xu
  Renal Failure.2024;[Epub]     CrossRef
• Association of serum Nrf2 protein levels with disease activity and renal impairment in lupus nephritis
  Jicui Li, Qiaoyan Guo, Xianping Wei, Yuexin Zhu, Manyu Luo, Ping Luo
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Effects of Qidan Tangshen Granule on diabetic kidney disease in patients with type 2 diabetes
  Hua Yang, Shisi Xia, Yilei Cong, Xinyu Yang, Jie Min, Tengfei Wu
  Diabetes Research and Clinical Practice.2024; 209: 111128.     CrossRef
• Comparison of conventional mathematical model and machine learning model based on recent advances in mathematical models for predicting diabetic kidney disease
  Yingda Sheng, Caimei Zhang, Jing Huang, Dan Wang, Qian Xiao, Haocheng Zhang, Xiaoqin Ha
  DIGITAL HEALTH.2024;[Epub]     CrossRef
• Network Pharmacology, Molecular Docking, and Experimental Verification to Reveal the Mitophagy-Associated Mechanism of Tangshen Formula in the Treatment of Diabetic Nephropathy
  Yinfeng Chen, Xiaying Wang, Jie Min, Jie Zheng, Xuanli Tang, Xiaoling Zhu, Dongrong Yu, De Jin
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 739.     CrossRef
• Senolytic combination of dasatinib and quercetin protects against diabetic kidney disease by activating autophagy to alleviate podocyte dedifferentiation via the Notch pathway
  Xinwang Zhu, Congxiao Zhang, Linlin Liu, Li Xu, Li Yao
  International Journal of Molecular Medicine.2024;[Epub]     CrossRef
• Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter‐2 inhibitors
  Chun‐Huei Chiu, Wei‐Yao Wang, Hung‐Yi Chen, Pei‐Lun Liao, Gwo‐Ping Jong, Tsung‐Yuan Yang
  Cancer Science.2024;[Epub]     CrossRef
• System Biology Approaches for Systemic Diseases: Emphasis on Type II Diabetes Mellitus and Allied Metabolism
  Mohan Das, Moumita Chakraborty, Promi Das, Sayantan Santra, Abhishek Mukherjee, Sarobi Das, Krisztian Banyai, Souvik Roy, Lopamudra Choudhury, Rudrak Gupta, Tama Dey, Dibya Das, Anirbandeep Bose, Balasubramanian Ganesh, Rintu Banerjee
  Biocatalysis and Agricultural Biotechnology.2024; : 103176.     CrossRef
• Beneficial effects of ginsenosides on diabetic nephropathy: A systematical review and meta-analysis of preclinical evidence
  Xiao-Mei Chen, Gui-Xuan Lin, Xue Wang, Hong-Yan Ma, Ru-Shang Wang, Shu-Mei Wang, Dan Tang
  Journal of Ethnopharmacology.2023; 302: 115860.     CrossRef
• Waist circumference and end‐stage renal disease based on glycaemic status: National Health Insurance Service data 2009–2018
  Yun Kyung Cho, Ji Hye Huh, Shinje Moon, Yoon Jung Kim, Yang‐Hyun Kim, Kyung‐do Han, Jun Goo Kang, Seong Jin Lee, Sung‐Hee Ihm
  Journal of Cachexia, Sarcopenia and Muscle.2023; 14(1): 585.     CrossRef
• A Narrative Review of New Treatment Options for Diabetic Nephropathy
  Aadhira Pillai, Darshna Fulmali
  Cureus.2023;[Epub]     CrossRef
• Shenkang recipe alleviates renal aging in diabetic kidney disease by interfering with the lysine-specific demethylase KDM6B to modulate the PPAR-γ signaling pathway
  Anna Zuo, Jiarun Xie, Junqiao Shao, Shuyu Li, Haoyu Lin, Shaoting Wang, Wei Sun, Jinjin Xia, Weiqiang Jiang, Jia Sun, Ming Wang
  Pharmacological Research - Modern Chinese Medicine.2023; 6: 100216.     CrossRef
• miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway
  Ping Tang, Yushan Xu, Jingrong Zhang, Juanli Nan, Ruxian Zhong, Jingmei Luo, Dazhi Xu, Shaoqing Shi, Lihua Zhang
  Biochemical and Biophysical Research Communications.2023; 648: 50.     CrossRef
• miR‐124‐3p improves mitochondrial function of renal tubular epithelial cells in db/db mice
  Luqun Liang, Chunxin Wo, Yao Yuan, Hongjuan Cao, Wanlin Tan, Xingcheng Zhou, Dan Wang, Rongyu Chen, Mingjun Shi, Fan Zhang, Ying Xiao, Lingling Liu, Yuxia Zhou, Tian Zhang, Yuanyuan Wang, Bing Guo
  The FASEB Journal.2023;[Epub]     CrossRef
• Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases
  Satoshi Yamasaki, Takahiko Horiuchi
  Hematology Reports.2023; 15(1): 180.     CrossRef
• Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for Diabetic Kidney Disease in patients with type 2 diabetes mellitus
  Amul Badr, Omayma Elkholy, Mona Said, Sally Fahim, Mohamed El-Khatib, Dina Sabry, Radwa Gaber
  Journal of Medical Biochemistry.2023; 42(2): 239.     CrossRef
• The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease
  Vivek Akhouri, Syamantak Majumder, Anil Bhanudas Gaikwad
  Life Sciences.2023; 321: 121643.     CrossRef
• Klotho’s impact on diabetic nephropathy and its emerging connection to diabetic retinopathy
  Anqi Tang, Yu Zhang, Ling Wu, Yong Lin, Lizeyu Lv, Liangbin Zhao, Bojun Xu, Youqun Huang, Mingquan Li
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Differences and Clinical Significance of Serum 25-Hydroxyvitamin D3 and Vasohibin-1 (VASH-1) Levels in Patients with Diabetic Nephropathy and Different Renal Injuries
  Hui Liu, Dongyan Wang, Jingnan Tang, Linlin Yu, Shanshan Su
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1085.     CrossRef
• Medial Arterial Calcification and the Risk of Amputation of Diabetic Foot Ulcer in Patients With Diabetic Kidney Disease
  Joon Myeong So, Ji Ho Park, Jin Gyeong Kim, Il Rae Park, Eun Yeong Ha, Seung Min Chung, Jun Sung Moon, Chul Hyun Park, Woo-Sung Yun, Tae-Gon Kim, Woong Kim, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
  Baranca Buijsers, Marjolein Garsen, Mark de Graaf, Marinka Bakker-van Bebber, Chunming Guo, Xue Li, Johan van der Vlag
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Influence of non-alcoholic steatohepatitis on the renal functional status in patients with type 2 diabetes and diabetic kidney disease
  Z.Ya. Кotsiubiichuk, O.S. Khukhlina, А.А. Аntoniv, O.Ye. Mandryk
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(2): 100.     CrossRef
• Roles of extracellular vesicles in ageing-related chronic kidney disease: Demon or angel
  Siqi Yin, Zixuan Zhou, Peiwen Fu, Chaoying Jin, Peipei Wu, Cheng Ji, Yunjie Shan, Linru Shi, Min Xu, Hui Qian
  Pharmacological Research.2023; 193: 106795.     CrossRef
• Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer
  Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, Roberta Mazzucchelli
  Cancers.2023; 15(11): 3037.     CrossRef
• Risk factors for heart, cerebrovascular, and kidney diseases: evaluation of potential side effects of medications to control hypertension, hyperglycemia, and hypercholesterolemia
  Kazumitsu Nawata
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)
  Marie Møller, Rikke Borg, Iain Bressendorff, Lisbeth N Fink, Eva Gravesen, Karina Haar Jensen, Torben Hansen, Dorrit Krustrup, Frederik Persson, Peter Rossing, Frederikke E Sembach, Anne C B Thuesen, Ditte Hansen
  BMJ Open.2023; 13(6): e072216.     CrossRef
• Oral Chinese patent medicines for diabetic kidney disease: An overview of systematic reviews
  Xue Xue, Ke-ying Li, Shang-zhi Liu, Jia-xuan Li, Xin-yan Jin, Xue-han Liu, La-mei Lin, Xin-rong Zou, Chun-li Lu, Fang-fang Zhao, Jian-ping Liu, Xiao-qin Wang
  European Journal of Integrative Medicine.2023; 61: 102269.     CrossRef
• Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models
  Ryosuke Saiki, Kan Katayama, Kaoru Dohi
  Biomedicines.2023; 11(7): 1803.     CrossRef
• Epigenetic regulation of angiogenesis and ischemic response by long noncoding RNA LEENE in diabetes
  Imari Mimura, Masaomi Nangaku
  Kidney International.2023; 104(6): 1048.     CrossRef
• Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress
  Ming Chen, Yao Chen, Wenhui Zhu, Xiaoming Yan, Jing Xiao, Peiqing Zhang, Peng Liu, Ping Li
  Biomedicine & Pharmacotherapy.2023; 165: 115088.     CrossRef
• A Systematic Review and Meta-Analysis on the Efficacy and Safety of Finerenone Therapy in Patients with Cardiovascular and Chronic Kidney Diseases in Type 2 Diabetes Mellitus
  FNU Jyotsna, Kamran Mahfooz, Tirath Patel, FNU Parshant, Fnu Simran, Fnu Harsha, Fnu Neha, Dev Jyotishna, Dipesh Mishra, Sirjana Subedi, Mahima Khatri, Satesh Kumar, Giustino Varrassi
  Cureus.2023;[Epub]     CrossRef
• Molecular implications of glycosaminoglycans in diabetes pharmacotherapy
  Tanya Waseem, Madiha Ahmed, Tausif Ahmed Rajput, Mustafeez Mujtaba Babar
  International Journal of Biological Macromolecules.2023; 247: 125821.     CrossRef
• SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation
  Jasna Klen, Vita Dolžan
  Pharmaceutics.2023; 15(7): 1995.     CrossRef
• CUL3 induces mitochondrial dysfunction via MRPL12 ubiquitination in renal tubular epithelial cells
  Xingzhao Ji, Xiaoli Yang, Xia Gu, Lingju Chu, Shengnan Sun, Jian Sun, Peng Song, Qian Mu, Ying Wang, Xiaoming Sun, Dun Su, Tong Su, Shaoshuai Hou, Yao Lu, Chen Ma, Mingqiang Liu, Tianyi Zhang, Weiying Zhang, Yi Liu, Qiang Wan
  The FEBS Journal.2023; 290(22): 5340.     CrossRef
• HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  Chuanqiang Zhou, Min Wu, Gaolun Liu, Li Zhou
  Open Life Sciences.2023;[Epub]     CrossRef
• A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases
  Ilker Ates, Ayşe Didem Yılmaz, Brigitta Buttari, Marzia Arese, Luciano Saso, Sibel Suzen
  Brain Sciences.2023; 13(11): 1532.     CrossRef
• Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”
  Zhen Shen, Tao Cui, Yao Liu, Shuai Wu, Cong Han, Jie Li
  Phytomedicine.2023; 121: 155129.     CrossRef
• The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy
  He Sun, Tong Chen, Xin Li, Yonghong Zhu, Shuang Zhang, Ping He, Yali Peng, Qiuling Fan
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy
  Jian Lu, Xue Qi Li, Pei Pei Chen, Jia Xiu Zhang, Liang Liu, Gui Hua Wang, Xiao Qi Liu, Ting Ting Jiang, Meng Ying Wang, Wen Tao Liu, Xiong Zhong Ruan, Kun Ling Ma
  JCI Insight.2023;[Epub]     CrossRef
• SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathy
  Samarth Dwivedi, Atharva Chavan, Atish T. Paul
  Drug Discovery Today.2023; 28(10): 103754.     CrossRef
• Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia
  Tomotaka Yamazaki, Imari Mimura, Yu Kurata, Tetsuhiro Tanaka, Masaomi Nangaku
  Physiological Reports.2023;[Epub]     CrossRef
• GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis
  Xiang Li, Xiao Jiang, Mei Jiang, Zhi-feng Wang, Tao Zhao, Si-ming Cao, Qiu-Mei Li
  Acta Diabetologica.2023; 61(2): 225.     CrossRef
• Highly Sensitive, Portable Detection System for Multiplex Chemiluminescence Analysis
  Yannan Yu, Wei Nie, Kaiqin Chu, Xi Wei, Zachary J. Smith
  Analytical Chemistry.2023; 95(39): 14762.     CrossRef
• From normal population to prediabetes and diabetes: study of influencing factors and prediction models
  Di Gong, Xiaohong Chen, Lin Yang, Yongjian Zhang, Qianqian Zhong, Jing Liu, Chen Yan, Yongjiang Cai, Weihua Yang, Jiantao Wang
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Diabetes Monitoring through Urine Analysis Using ATR-FTIR Spectroscopy and Machine Learning
  Sajid Farooq, Denise Maria Zezell
  Chemosensors.2023; 11(11): 565.     CrossRef
• Treatment and practical considerations of diabetic kidney disease
  Yara Bilen, Allaa Almoushref, Kenda Alkwatli, Omar Osman, Ali Mehdi, Hanny Sawaf
  Frontiers in Medicine.2023;[Epub]     CrossRef
• Application of Metabolomics and Traditional Chinese Medicine for Type 2 Diabetes Mellitus Treatment
  Jing Li, Na Zhu, Yaqiong Wang, Yanlei Bao, Feng Xu, Fengjuan Liu, Xuefeng Zhou
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 4269.     CrossRef
• Cardiovascular autonomic neuropathy and incident diabetic kidney disease in patients with type 2 diabetes
  Ji Eun Jun, Min Sun Choi, Jae Hyeon Kim
  Diabetes Research and Clinical Practice.2022; 184: 109181.     CrossRef
• Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
  Martin Ho Yin Yeung, Ka Long Leung, Lai Yuen Choi, Jung Sun Yoo, Susan Yung, Pui-Kin So, Chi-Ming Wong
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
  Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo
  Kidney Research and Clinical Practice.2022; 41(2): 136.     CrossRef
• Evolving Type 2 diabetes management focuses on clinical outcomes
  Caroline Fenton, Connie Kang
  Drugs & Therapy Perspectives.2022; 38(4): 165.     CrossRef
• Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
  Chan-Young Jung, Tae-Hyun Yoo
  Diabetes & Metabolism Journal.2022; 46(2): 181.     CrossRef
• Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes
  Il Rae Park, Jimi Choi, Eun Young Ha, Seung Min Chung, Jun Sung Moon, Sehyun Shin, Sin Gon Kim, Kyu Chang Won
  Clinical Hemorheology and Microcirculation.2022; 81(4): 293.     CrossRef
• Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells
  Donghee Kim, Ga-Young Nam, Eunhui Seo, Hee-Sook Jun
  Journal of Biomedical Science.2022;[Epub]     CrossRef
• The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
  Yuji Oe, Volker Vallon
  Kidney and Dialysis.2022; 2(2): 349.     CrossRef
• Dapagliflozin for the treatment of chronic kidney disease
  Yu Kurata, Masaomi Nangaku
  Expert Review of Endocrinology & Metabolism.2022; 17(4): 275.     CrossRef
• Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
  Javier Donate-Correa, María Dolores Sanchez-Niño, Ainhoa González-Luis, Carla Ferri, Alberto Martín-Olivera, Ernesto Martín-Núñez, Beatriz Fernandez-Fernandez, Víctor G Tagua, Carmen Mora-Fernández, Alberto Ortiz, Juan F Navarro-González
  Clinical Kidney Journal.2022; 15(12): 2200.     CrossRef
• Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells
  Himanshu Sankrityayan, Ajinath Kale, Vishwadeep Shelke, Anil Bhanudas Gaikwad
  Archives of Physiology and Biochemistry.2022; : 1.     CrossRef
• Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress
  Debra Dorotea, Songling Jiang, Eun Seon Pak, Jung Beom Son, Hwan Geun Choi, Sung-Min Ahn, Hunjoo Ha
  Experimental & Molecular Medicine.2022; 54(8): 1086.     CrossRef
• Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
  Nam Hoon Kim, Nan Hee Kim
  Diabetes & Metabolism Journal.2022; 46(4): 543.     CrossRef
• Effect of once-weekly dulaglutide on renal function in patients with chronic kidney disease
  Sungmin Kim, Jung Nam An, Young Rim Song, Sung Gyun Kim, Hyung Seok Lee, AJin Cho, Jwa-Kyung Kim, Tomislav Bulum
  PLOS ONE.2022; 17(8): e0273004.     CrossRef
• Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
  Daniela Maria Tanase, Evelina Maria Gosav, Madalina Ioana Anton, Mariana Floria, Petronela Nicoleta Seritean Isac, Loredana Liliana Hurjui, Claudia Cristina Tarniceriu, Claudia Florida Costea, Manuela Ciocoiu, Ciprian Rezus
  Biomolecules.2022; 12(9): 1227.     CrossRef
• Preventive and healing effect of high dosing grape seed flour on CKD patients of various stages and aetiologies
  Wiem Bejaoui, Mohamed Mahmoudi, Kamel Charradi, Monia Abbes-Belhadj, Habib Boukhalfa, Mossadok Ben-Attia, Ferid Limam, Ezzedine Aouani
  Biomarkers.2022; 27(8): 795.     CrossRef
• Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics
  Miyesaier Abudureyimu, Xuanming Luo, Xiang Wang, James R Sowers, Wenshuo Wang, Junbo Ge, Jun Ren, Yingmei Zhang, Wei-Ping Jia
  Journal of Molecular Cell Biology.2022;[Epub]     CrossRef
• Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases
  Wei Huang, Yi-Yuan Chen, Zi-Qi Li, Fang-Fang He, Chun Zhang
  International Journal of Molecular Sciences.2022; 23(18): 10882.     CrossRef
• Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus
  Chuan Wang, Mingyue Xu, Ruiying Feng, Lei Zhang, Xiaofei Yin, Ruoqi Feng, Kai Liang, Jinbo Liu
  BMJ Open Diabetes Research & Care.2022; 10(5): e002972.     CrossRef
• hucMSC-sEVs-Derived 14-3-3ζ Serves as a Bridge between YAP and Autophagy in Diabetic Kidney Disease
  Siqi Yin, Wanzhu Liu, Cheng Ji, Yuan Zhu, Yunjie Shan, Zixuan Zhou, Wenya Chen, Leilei Zhang, Zixuan Sun, Wenqin Zhou, Hui Qian, Chaoliang Tang
  Oxidative Medicine and Cellular Longevity.2022; 2022: 1.     CrossRef
• Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
  Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, Keizo Kanasaki, Hunjoo Ha
  Kidney Research and Clinical Practice.2022; 41(Suppl 2): S74.     CrossRef
• REDD1 Ablation Attenuates the Development of Renal Complications in Diabetic Mice
  Siddharth Sunilkumar, Esma I. Yerlikaya, Allyson L. Toro, William P. Miller, Han Chen, Kebin Hu, Scot R. Kimball, Michael D. Dennis
  Diabetes.2022; 71(11): 2412.     CrossRef
• The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
  Huixia Liu, Yujuan Li, Jing Xiong
  Molecules.2022; 27(21): 7318.     CrossRef
• Resistant Starch as a Dietary Intervention to Limit the Progression of Diabetic Kidney Disease
  Anna M. Drake, Melinda T. Coughlan, Claus T. Christophersen, Matthew Snelson
  Nutrients.2022; 14(21): 4547.     CrossRef
• Aggravated renal fibrosis is positively associated with the activation of HMGB1-TLR2/4 signaling in STZ-induced diabetic mice
  Yan Yuan, Yuanxia Liu, Mengyao Sun, Huijing Ye, Yuchen Feng, Zhenzhen Liu, Lingyu Pan, Hongbo Weng
  Open Life Sciences.2022; 17(1): 1451.     CrossRef
• Single-cell multiomics reveals the complexity of TGFβ signalling to chromatin in iPSC-derived kidney organoids
  Jessica L. Davis, Ciaran Kennedy, Shane Clerkin, Niall J. Treacy, Thomas Dodd, Catherine Moss, Alison Murphy, Derek P. Brazil, Gerard Cagney, Dermot F. Brougham, Rabi Murad, Darren Finlay, Kristiina Vuori, John Crean
  Communications Biology.2022;[Epub]     CrossRef
• Oxidized Albumin: Evaluation of Oxidative Stress as a Marker for the Progression of Kidney Disease
  Hiroshi Watanabe
  Biological and Pharmaceutical Bulletin.2022; 45(12): 1728.     CrossRef
• Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study
  Tingli Wang, Junlin Zhang, Yiting Wang, Lijun Zhao, Yucheng Wu, Honghong Ren, Yutong Zou, Rui Zhang, Huan Xu, Zhonglin Chai, Mark Cooper, Jie Zhang, Fang Liu
  Journal of Clinical Medicine.2022; 12(1): 88.     CrossRef
• What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances
  Kimio Watanabe, Emiko Sato, Eikan Mishima, Mariko Miyazaki, Tetsuhiro Tanaka
  International Journal of Molecular Sciences.2022; 24(1): 570.     CrossRef
• Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis
  Zhiyue Zhu, Qi Zhang, Le Liu, Pengjie Bao, Shilin Liu, Chaoqun Song, Wenbo Yang, Zheng Nan
  Medicine.2022; 101(49): e31490.     CrossRef
• Cudrania tricuspidata Root Extract Prevents Methylglyoxal-Induced Inflammation and Oxidative Stress via Regulation of the PKC-NOX4 Pathway in Human Kidney Cells
  Donghee Kim, Jayeon Cheon, Haelim Yoon, Hee-Sook Jun, Evangelia Dounousi
  Oxidative Medicine and Cellular Longevity.2021; 2021: 1.     CrossRef
• Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
  Tomoaki Takata, Hajime Isomoto
  International Journal of Molecular Sciences.2021; 22(9): 4374.     CrossRef
• HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
  Kiichi Hirota
  Biomedicines.2021; 9(5): 468.     CrossRef
• Nephropathie bei Diabetes
  Roland E. Schmieder
  CardioVasc.2021; 21(3): 31.     CrossRef
• Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study
  Francesco Fontana, Rossella Perrone, Francesco Giaroni, Gaetano Alfano, Silvia Giovanella, Giulia Ligabue, Riccardo Magistroni, Gianni Cappelli, Udeme Ekrikpo
  International Journal of Nephrology.2021; 2021: 1.     CrossRef
• Activated Histone Acetyltransferase p300/CBP-Related Signalling Pathways Mediate Up-Regulation of NADPH Oxidase, Inflammation, and Fibrosis in Diabetic Kidney
  Alexandra-Gela Lazar, Mihaela-Loredana Vlad, Adrian Manea, Maya Simionescu, Simona-Adriana Manea
  Antioxidants.2021; 10(9): 1356.     CrossRef
• Plasma and urine biomarkers in chronic kidney disease: closer to clinical application
  Azadeh Zabetian, Steven G. Coca
  Current Opinion in Nephrology & Hypertension.2021; 30(6): 531.     CrossRef
• Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
  Fanrui Meng, Yukai Cao, Mir Hassan Khoso, Kai Kang, Guiping Ren, Wei Xiao, Deshan Li
  Archives of Biochemistry and Biophysics.2021; 713: 109063.     CrossRef
• Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
  Daiji Kawanami, Yuichi Takashi, Yoshimi Muta, Naoki Oda, Dai Nagata, Hiroyuki Takahashi, Makito Tanabe
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Transcription Factor ChREBP Mediates High Glucose-Evoked Increase in HIF-1α Content in Epithelial Cells of Renal Proximal Tubules
  Aleksandra Owczarek, Katarzyna B. Gieczewska, Robert Jarzyna, Zuzanna Frydzinska, Katarzyna Winiarska
  International Journal of Molecular Sciences.2021; 22(24): 13299.     CrossRef
• The effect of modern hypoglycemic therapy on the course of chronic kidney disease in patients with type 2 diabetes mellitus
  V.I. Katerenchuk
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(8): 624.     CrossRef

As a member of the class IIa histone deacetylases (HDACs), HDAC9 catalyzes the deacetylation of histones and transcription factors, commonly leading to the suppression of gene transcription. The activity of HDAC9 is regulated transcriptionally and post-translationally. HDAC9 is known to play an essential role in regulating myocyte and adipocyte differentiation and cardiac muscle development. Also, recent studies have suggested that HDAC9 is involved in the pathogenesis of chronic diseases, including cardiovascular diseases, osteoporosis, autoimmune disease, cancer, obesity, insulin resistance, and liver fibrosis. HDAC9 modulates the expression of genes related to the pathogenesis of chronic diseases by altering chromatin structure in their promotor region or reducing the transcriptional activity of their respective transcription factors. This review summarizes the current knowledge of the regulation of HDAC9 expression and activity. Also, the roles of HDAC9 in the pathogenesis of chronic diseases are discussed, along with potential underlying mechanisms.

Citations

Citations to this article as recorded by  

• Impact of housing temperature on adipose tissue HDAC9 expression and adipogenic differentiation in high fat‐fed mice
  Samah Ahmadieh, Brandee Goo, Abdalrahman Zarzour, David Kim, Hong Shi, Praneet Veerapaneni, Ronnie Chouhaita, Nicole K. H. Yiew, Carla Dominguez Gonzalez, Akash Chakravartty, James Pennoyer, Nazeera Hassan, Tyler W. Benson, Mourad Ogbi, David J. Fulton, R
  Obesity.2024; 32(1): 107.     CrossRef
• HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD
  Guixian Zheng, Chao Li, Xiaoli Chen, Zhaohui Deng, Ting Xie, Zengyu Huo, Xinyan Wei, Yanbing Huang, Xia Zeng, Yu Luo, Jing Bai
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(3): 167023.     CrossRef
• Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes
  Jing Liu, Lingzhen Meng, Zhihong Liu, Ming Lu, Ruiying Wang
  Scientific Reports.2024;[Epub]     CrossRef
• HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors
  Totan Das, Samima Khatun, Tarun Jha, Shovanlal Gayen
  Mini-Reviews in Medicinal Chemistry.2024; 24(7): 767.     CrossRef
• Targeting histone deacetylases for cancer therapy: Trends and challenges
  Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
  Acta Pharmaceutica Sinica B.2023; 13(6): 2425.     CrossRef
• Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
  Guokai Zhang, Zhenying Liu, Zihan Li, Bing Zhang, Pengyu Yao, Yun Qiao
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Research Progress on Histone Deacetylase Inhibitors
  玉姜 汤
  Hans Journal of Medicinal Chemistry.2023; 11(02): 116.     CrossRef
• HDAC9 Inhibition as a Novel Treatment for Stroke
  Hugh S. Markus
  Stroke.2023; 54(12): 3182.     CrossRef
• Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
  Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi
  Pharmacological Research.2023; 198: 107009.     CrossRef
• Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration
  Ming Lei, Hui Lin, Deyao Shi, Pan Hong, Hui Song, Bomansaan Herman, Zhiwei Liao, Cao Yang
  Cellular & Molecular Biology Letters.2023;[Epub]     CrossRef
• Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
  Sylvia Fong, Bridget Yates, Choong-Ryoul Sihn, Aras N. Mattis, Nina Mitchell, Su Liu, Chris B. Russell, Benjamin Kim, Adebayo Lawal, Savita Rangarajan, Will Lester, Stuart Bunting, Glenn F. Pierce, K. John Pasi, Wing Yen Wong
  Nature Medicine.2022; 28(4): 789.     CrossRef
• Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
  Michael Hauke, Robert Eckenstaler, Anne Ripperger, Anna Ender, Heike Braun, Ralf A. Benndorf
  Journal of the American Heart Association.2022;[Epub]     CrossRef
• HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
  Long Xu, Jian Wang, Buhan Liu, Jiaying Fu, Yuanxin Zhao, Sihang Yu, Luyan Shen, Xiaoyu Yan, Jing Su
  Biomedicines.2022; 10(2): 374.     CrossRef
• Common protein-coding variants influence the racing phenotype in galloping racehorse breeds
  Haige Han, Beatrice A. McGivney, Lucy Allen, Dongyi Bai, Leanne R. Corduff, Gantulga Davaakhuu, Jargalsaikhan Davaasambuu, Dulguun Dorjgotov, Thomas J. Hall, Andrew J. Hemmings, Amy R. Holtby, Tuyatsetseg Jambal, Badarch Jargalsaikhan, Uyasakh Jargalsaikh
  Communications Biology.2022;[Epub]     CrossRef
• Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life
  Zahra Salehi, Masoud Arabfard, Omid Sadatpour, Mina Ohadi
  Neurological Sciences.2021; 42(3): 951.     CrossRef
• Emerging roles of SIRT6 in human diseases and its modulators
  Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou
  Medicinal Research Reviews.2021; 41(2): 1089.     CrossRef
• Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9
  Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, Teresa Gagliano
  Life.2021; 11(2): 90.     CrossRef
• circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis
  Huan Wan, Ting You, Wei Luo
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
  Chun Yang, Stéphane Croteau, Pierre Hardy
  Cellular Oncology.2021; 44(5): 997.     CrossRef
• Dual HDAC/BRD4 inhibitors against cancer
  Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
  Medicinal Chemistry Research.2021; 30(10): 1822.     CrossRef
• miR‐211‐5p is down‐regulated and a prognostic marker in bladder cancer
  Weisheng Wang, Zhiming Liu, Xuegang Zhang, Junning Liu, Junqing Gui, Maorong Cui, Yong Li
  The Journal of Gene Medicine.2020;[Epub]     CrossRef